Search again

Keywords


Location




Filter by sector


Narrow by resource type







Search
Back


Article

Creative targets: Innovations in drug delivery

David Harris and Ross Jones at Sagentia look at innovations in drug delivery, and ask whether the drive for quality is stifling creativity - article taken from PMPS magazine, Autumn 2010.

A drive for uniformity – from drug formulation to packaging and dispatching – has always characterised the pharmaceutical industry, leading to the exceptional quality required by regulators today and expected by practitioners and patients. In order to ensure this uniformity throughout the drug development process, the use of formal quality, testing and process control methodologies (such as Six Sigma and QFD) has become more widespread.

Although such methodologies can significantly improve quality and efficiency within the process environment, their use is now extending into areas such as innovation. In this context, there is a significant risk that the underlying philosophy of control that process methodologies promote can contradict the free exploration of ideas necessary for true breakthroughs in product development.

Is quality therefore stifling innovation? If so, how can a workable compromise be achieved?

Download the full article from the Autumn 2010 edition of PMPS magazine below.
PMPS Autumn 2010 (PDF)

Get in touch

Contact us via email

Email newsletters

Keep up to date - sign up for our e-newsletters
Certified